Johns Hopkins Diabetes GuideClinical TestsGlucose Monitoring

Hemoglobin A1c

Thomas Donner, M.D., Christopher Saudek, M.D.
Hemoglobin A1c is a topic covered in the Johns Hopkins Diabetes Guide.

To view the entire topic, please or purchase a subscription.

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

Johns Hopkins Guides

-- The first section of this topic is shown below --

DESCRIPTION

  • Hemoglobin A1c (HbA1c) is a stable adduct of glucose on the beta-chain of hemoglobin (N-[1-deoxyfructosyl]hemoglobin).
  • Formed by a largely irreversible reaction, post-translationally and non-enzymatically, when hemoglobin circulating in a red blood cell is exposed to ambient glucose
  • Alternate terms: "A1c" (preferred for use in communication with patients), "glycated hemoglobin" (the most accurate term), glycosylated hemoglobin.
  • Expressed most often as the percent of hemoglobin that is glycated (alternatively, as mmol glycated hemoglobin per mole total hemoglobin).
  • The single best test to monitor overall blood glucose control in diabetes[6]
  • Reflects the average blood glucose over about 3 months previously, although somewhat disproportionately weighted to recent blood glucose levels[12]
  • A strong indicator of risk for long-term diabetic complications, especially retinopathy, neuropathy and nephropathy (DCCT).
  • Also an indicator of cardiovascular disease (CVD) risk, although glucose control is less strong of a risk factor for CVD than lipids, blood pressure and smoking[8]
  • Recently, HbA1c > 6.5% is recommended as a criterion for diagnosing diabetes[2][3].

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: July 31, 2016